Yahoo Finance

Christopher Smernoff

Thanks, Larry, and good morning everyone. Please turn to slide 6. For the fourth quarter, we reported a net loss of $0.07 per share and adjusted distributable earnings of $0.27 per share. Our overall net interest margin remains strong at 5.07% supported by our growing capital allocation to CLOs.
On slide 7, you can see the net income breakdown by strategy, which was $0.10 per share from CLOs and negative $0.12 from agency. In our CLO debt portfolio, net interest income grew quarter over quarter, and we also had net gains in our US and European debt portfolios, supported by several opportunistic sales, tighter credit spreads, and redemption of several of our discount seasoned CLO mezzanine tranches.
In our CLO equity portfolio, results were modestly positive, with net interest income slightly exceeding net unrealized losses. Meanwhile, the agency's strategy generated a net loss for the quarter as rising interest rates and intra-quarter volatility drove underperformance of our agency RMBS relative to hedging instruments market-wide.
And finally, our non-agency RMBS portfolio generated positive results driven by net interest income and profitable sales. We sold effectively all of our remaining non-agency RMBS and interest only securities during the quarter at net gains. With an overall net loss for the quarter, we accrued a small income tax benefit.
After our conversion to a closed-end fund slash RIC next month, we will generally not be subject to corporate income tax. At December 31, our book value per share was $6.53 and combined cash and unencumbered assets totaled $111 million. Our economic return for the quarter was 1.2%. Our debt to equity ratio adjusted for unsettled trades increased to 2.9 times from 2.5 times at September 30.
Over the same period, our net mortgage assets to equity ratio decreased to 2.6 times from 3 times, driven by a net short notional TBA position at year end, in contrast to a net long notional TBA position at the end of the third quarter, as well as higher shareholders equity. By 10 shows our CLO portfolio increasing by 18% to $171 million at year end, and capital allocated to CLOs expanding to 72% from 58% at September 30.
At December 31, CLO equity comprised 50% of our total CLO holdings, up from 52%, and European CLO investments constituted 14% of our total CLO holdings down from 17%. On slide 11, we show the agency RMBS Holdings increased by 11% to $512 million at year end.
Slide 12 details our interest rate hedging portfolio. And slide 13, our net RMBS exposure, where you can see the net short notional TBA position at December 31, which has grown significantly post year end. On site 14, we illustrate that nearly all of the loans underlying our CLO portfolio are floating rate, and as such have much lower interest rate duration than agency RMBS.
We also maintained modest credit hedge and foreign currency hedge portfolios at year end related to our CLO investments.
With that, I'll pass it over to Greg.

Greg Borenstein

Thanks, Chris.
It's nice to speak with everyone today. Overall, we saw strong performance in the CLO portfolio for the fourth quarter. Our CLO meds positions did particularly well. Spread tightening provided a nice tailwind, and we were able to enhance our total return with some opportunistic sales and a few deal calls.
GLO equity generally held in, aided by a benign credit environment and continued to strengthen the leverage loan prices. However, similar to the prior quarter, the high pre-payment rates in the loan market combined with loan coupon spread compression did lead to muted returns in some areas of the CLO equity market and in our portfolio as well.
With the majority of the refinance loans previously trading above par, that refinancing activity coupled with some credit losses from lower quality loans underlying CLO portfolios weighed slightly on equity NAVs in the market. Further, coupon spread compression and newly refinanced loans caused a decrease in net interest margins for many CLOs, and thus, A decrease in net interest distributions to the equity tranches for the equity tranches in those CLOs.
These asset-level dynamics created headwinds for CLO equity investments. This said, some of these headwinds were offset by refinancing and resetting CLO liabilities at tighter coupons, which improved net interest margins for many CLOs. We often talk about cross currents in CLO equity, and these are prime examples.
Even some deals that did not benefit from their liabilities tightening did experience price appreciation, as the option to refinance going forward gained value. These dynamics can also present us with trading opportunities.
We do expect the repricing wave to relent as 2025 progresses for the universe of loans backing US broadly syndicated CLOs, we have already seen the percentage trading at a premium decline from 63% at the end of January to 32% at the end of February, and this percentage has declined even further in March.
Meanwhile, in Europe, many of these dynamics also exist, but to a lesser degree. As a result, our CLO equity in Europe has strong returns in Q4, outperforming our CLO equity in the US. I think that's a good example of the power of diversification. There was also far less CLO capital markets activity in Europe in 2024, and crediteds have generally not tightened as much.
As we move forward in 2025, credit spread tightening and monetization of discount debt tranches have seen this increasingly shift the portfolio to CLO equity. Despite year-to-date declines, interest rates remain relatively elevated, and that continues to drive demand for floating rate loans and CLO debt tranches. However, we remain cautious given potential longer term fundamental stresses on corporate borrowers.
We expect to see more opportunities and equity as the deluge of issuance is creating both ample supply and also pricing and efficiencies. We continue to focus on maintaining sufficient liquidity to enable us to remain nimble and tactically shift to new opportunities as we see them.
In recent days, credit market volatility has surged once again. Outside of last August's flash crash and the sharp interest rate sell-off triggered by inflation concerns a few months prior, implied volatility in the CBX high yield index recently reached its highest level since late 2023.
As is often the case, heightened volatility brings greater market inefficiencies and a more dynamic trading environment. As a result, we are seeing an expanding opportunities set in CLOs as we deploy new capital.
While this volatility has widened credit spreads in certain areas, creating a potential headwind to book value, our CLO equity positions are generally well positioned to capitalize on the shifting landscape. The risk of loan coupon spread compression has eased significantly as a smaller portion of the loan market is now trading above par.
This structural shift benefits our CLO equity holdings, which are concentrated in profiles with locked-in liabilities and extended reinvestment periods. The current market conditions align well with our expertise in active trading and relative value assessment, reinforcing our ability to capitalize on market inefficiencies and drive strong risk adjusted returns.
Also, keep in mind that we will have lots of dry powders to deploy once we sell off our remaining agency mortgage pools. So our anticipated April 1, conversion date may prove to be well timed.
Now I'll turn it over to Mark to discuss the agency strategy.

Mark Tecotzky

Thanks, Greg.
We had a small loss in our agency MBS portfolio for the fourth quarter. That was largely a result of very high levels of interest rate volatility and general underperformance of agency MBS versus hedging instruments. I'd like to highlight how we've changed the composition of our hedging portfolio since year end.
As Larry mentioned, we have substantially de-risked our agency MBS portfolio recently by significantly increasing our short TBA hedging positions. Today, our short TBA position essentially offsets all of our agency MBS basis exposure. So if we were to update the bar chart on slide 13, as of today, you would see a TBA short offsetting almost all of our long pool exposure.
With this positioning, we are keeping our pool investments in place for 1940 Act compliance reasons up until conversion, but we're also significantly limiting our overall exposure to the agency sector. I am pleased with how we were positioned at year end, which enabled us to generate strong profitability in our MBS portfolio in January.
I am also pleased that we increased our TBA hedges earlier this quarter, especially in light of the volatility we've seen so far in March. The last step following the conversion will be to sell our pools and buy back the TBA shorts, at which point we will no longer have any MBS-related positions.
Now back to Larry.

Laurence Penn

Thanks Mark.
These past 15 or so months have been extraordinary for Ellington Credit Company as we undertook the highly complex task of converting from a mortgage ree to a CLO focused closed and fund.
Achieving this breakthrough was only possible through extensive planning and collaborative efforts since late 2023 involving our board, our management team, and our expert advisors. Above all else, it was extremely rewarding to see the overriding support that our shareholders showed all along the way.
Over the course of 2024, we transformed our portfolio by increasing our capital allocation to CLOs from just 11% on January 1, to 72% by year end, achieved through a tenfold expansion of our CLO holdings, a careful but steady reduction of our agency RMBS portfolio, and a deliberate rotation of our agency RMBS portfolio into extremely liquid sectors.
Through strategic timing of pool sales by Ellington's MBS portfolio management team overseen by Mark Tecotzky combined with the success of Greg Borenstein's team in sourcing attractive CLO investments allowed us to minimize BAS costs and efficiently add CLOs without dis disrupting earnings along the way.
This smooth transition not only supported our earnings and boosted our net interest margin in 2024, but it also reduced our overall leverage and hedging requirements, and the market took notice of all of these metrics. Our stock, which began the year trading at a discounted book value per share, finished 2024 at a premium, helping generate a 24.6% total return for our shareholders.
Each step of the way, our risk, operations and accounting teams worked in harmony, adjusting hedges dynamically, optimizing financing, and ensuring continued 1940 Act compliance, all to facilitate the rotation. With the closed-end fund conversion approved. We expect to effectuate the transition on April 1, finally selling our remaining agency RMBS pools.
Looking forward post conversion, we project that we'll be starting the second quarter with a CLO portfolio not much larger than our total equity base. But of course, we plan to add some leverage from there consistent with the constraints applicable to closed-end funds.
We will be focused on balancing a swift ramp up with careful asset selection, and we expect to have a fully ramped CLO portfolio around mid-year. We are excited about the new opportunities that lie ahead. The conversion marks a momentous event for the company, positioning us to drive strong earnings and unlock greater value for shareholders over the long term.
As outlined on slide 5, we anticipate improved risk adjusted returns, enhanced access to capital markets, and greater tax efficiencies as a CLO closed-end fund. Finally, as Greg mentioned, recent market volatility in the credit markets may be generating a wave of compelling investment opportunities, which would set the stage for a robust deployment environment following our conversion.
Now let's open the floor to Q&A operator, please go ahead.

Question and Answer Session

Operator

(Operator Instructions) Doug Harter, UBS.

Doug Harter

Thanks. I was hoping you could help, size the amount of capital, that gets freed up April 1, when you're able to sell the agency portfolio, should we think about that as the other 28% that's not in CLOs or is there a portion that's kind of held back for liquidity, so if you could just help us frame that.

Laurence Penn

No, you got it right. Hey, Doug, thanks. Yeah, no, you got it right. I think 28% is a is a very reasonable estimate. Obviously we've got a few weeks to go before the end of the quarter, but, absolutely I think that's the right way to look at it and you know that timing could end up being it looks like it's being very fortunate, right, because with all the volatility, equity markets, credit markets, it looks like we're going to potentially have some very good entry points.
In the second quarter as we take that roughly 28% and deploy that what will be fresh capital shortly after the beginning of the quarter. So yeah, and we'll be -- I think appropriately patient. I said earlier that I estimate that we'll be fully ramped by mid-year and I still think that's probably about right, but.
In terms of how quickly we get there, how quickly we want to pounce on the opportunities that may be there at the beginning of the quarter we'll see, but it could be some could be very exciting the timing here.

Doug Harter

And I guess just on that the recent market volatility, just any way to frame, kind of how different parts of the CLO market have reacted and and where returns might be today versus, call it three months ago.

Laurence Penn

Greg.

Greg Borenstein

I'm happy to take that one. It's Greg. You've certainly seen things, react and move back. It depends upon the capital structure. I think that you've seen triple A's, not that we're holding any of those in here, move back, about $0.50. But these types of things come through and affect, the overall arb, and the securitizations. I think that you've seen equity, generally down, several points even for cleaner, stronger profiles.
It's really manager dependent, but you've certainly seen things ease off and back up even for the better quality names and then obviously the the hearing has become a little bit more pronounced, but you know the market's been functional and trading and so it it's been pretty transparent what's happened.

Doug Harter

And I guess how much obviously it's still early and there's a lot of uncertainty, but how much of like the change in equity prices do you think is it increasing maybe expected losses versus you know just to kind of increase or widening of the discount rate?

Greg Borenstein

I think it's probably more the latter. I think there's certainly some concerns, right? If you talk about The fundamental side, tariffs will create winners and losers, and if you create a series of losers in a portion of the corporate market, will that hurt, potentially the fundamentals of some of these companies, right? So that's certainly a concern about what could be happening.
In a portion of the low market, that being said, I think you're seeing a technical push on the rate side of the market. If we're looking at, gross slowing and potentially cuts, the demand for floating rate instruments you've started to see, potentially could be lessening. You've seen NAVs, for example, on equity start to back up a little bit, right, as loan prices drop and as floating rate. Demand, maybe eases, that will filter its way through too in terms of the spread widening.
We could get into a lot of different dynamics, I think as we've mentioned, sort of through earnings and on the call, the loan market had a negative convexity problem where you had spread compression because things were so strong and above par and refinancing, while prices will drop off and widen, you'll also see pre-payments slow down and so.
These are some of the dynamics at play which depending on the duration and the structure of the CLO deal, it really does separate out how it will affect different deals and different tranches.

Doug Harter

Great, appreciate the answers.

Laurence Penn

Hey Doug.
Yeah. Hi, it's Larry yeah I just wanted to maybe add a little more color along the lines of your question. So you know you can call this a little informal guidance here so you know the first quarter we you know we're going to have that 28% as of you know roughly as of as of year end, we're still going to have that mortgage portfolio through the entire quarter.
And so I think in terms of if you're thinking in terms of our adjusted distributable earnings, we were $0.27 in the fourth quarter. I think, there's no reason for us to think at this point that it's going to be much different from that in the first quarter, so I think that would be considered reasonable guidance. But now in the second quarter, as you pointed out, we're going to be.
Basically converting all that adjusted distributable earnings that were coming out of our mortgage portfolio into cash and then we're going to methodically, we'll see it may be slow, it may be fast but deploy that into CLOs which you know as you can see on the numbers here, 854 basis points net-interest margin, on credit, you know these are very wide interest margins, right? So. But nevertheless, right, having that 28% ish of the portfolio undeployed at the beginning of the quarter, we're definitely not going to be able to have the same level of ADE.
So for that second quarter, I think by the end of the second quarter and then looking into the third quarter, we'll be back to covering our dividends. But I would just, I would expect, and I think it's well worth it in terms of ramping up the CLO portfolio, getting the best investments in the portfolio that will probably miss by a few pennies versus the dividend in the second quarter. I just wanted to add that color.
But the third quarter I think but the third quarter, there's no reason to believe why we won't be, back covering dividend.

Operator

Thank you. Matthew Erdner, Jones Trading.

Matthew Erdner

Hey guys, thanks for taking the question and congrats on the updated or the upcoming conversion so when you think about the liquidity that you guys are going to get and how to deploy it, you mentioned the shift a little more into equity this quarter from the debt on the CLO side, how do you view those opportunities and, I know you want to remain diversified there, but I guess given the environment right now, would you kind of lean towards that equity side over the debt side?

Greg Borenstein

I think, it's Greg. We had when we first started buying CLOs in late 2023, we were buying a lot of mens positions. It was more heavily in me and it was me at at real discounts. As time went on and those positions sort of drifted up towards, par.
We shifted more into equity and then eventually more into specifically new issue equity sort of creating opportunities there. If the market becomes more dis-located and continues to sell off more, new issue markets may be tougher. You'll see more and more of the sourcing come from secondary. I mean, we are very comfortable, historically, trading more and doing it in the secondary market. In terms of if we start to shift back towards me, I think you would see that if more stress sort of came into the market. I think the selloff of me has been.
Not overly pronounced to this point, or I think it would. Caused me to say that we would expect, more double theses to enter the portfolio relative to equity than we maybe otherwise would have, claimed a month or two ago.
But overall, it's something that becomes probably an increased probability, with more stress looking at these opportunities in secondary, the other thing to consider too is If this is coming because rates are being cut, that obviously will affect coupons on the meds as well, right. And so it's something else to consider how the widening occurs.

Matthew Erdner

Yeah, I got it. That that makes sense and that's helpful there. And then, I guess kind of as a follow up to that, say look at the end of 2Q, 3Q in terms of leverage, I guess what are you guys able to work with and is there a target range that you guys, are expecting to kind of, I guess sit in once you're fully invested in CLOs.

Laurence Penn

Sorry, could you repeat that? I didn't catch that.

Matthew Erdner

Sorry about that. Leverage, once you're fully invested in CLOs, is there a range that you want to sit in and I guess what's the upper bound of your limitations, given as an investment company there.

Laurence Penn

Right, okay. So, it's a little nuanced the answer, I would say that half a turn of leverage is a reasonable estimate. And I would also say that looking forward again.this is really looking forward past the second quarter maybe at some point in the third quarter we could, consider doing a debt deal.
One other advantage, I mentioned access to the capital markets being better as a closed in fund. So when closed in funds tap the unsecured note market, they get better financing than, for example, mortgage rates have done. So yeah, so really looking forward we could even go higher than that, we, plan to be what's called the fully compliant derivatives user, and I want to get into all the details there, but that gives us a little more flexibility.
On leverage than some other 1940 act companies so but I think just. Out of the gate, I think half the turn of leverage is kind of a reasonable benchmark to think of. So for, every say $100 million of common equity, think of [$150 million] worth of CLOs.

Operator

And that was our final question for today. We thank you for participating in the Ellington Credit Company 2024, fourth quarter financial results conference call.
You may disconnect your line at this time and have a wonderful day.